Subcutaneous and Intravenous Cladribine Treatment of Hairy Cell Leukemia Patients: Do We Still Need Intravenous Cladribine?
Turkish journal of internal medicine（2023）
摘要
Background Hairy cell leukemia (HCL) is an uncommon neoplasm representing approximately 2% leukemias and
更多查看译文
关键词
hairy cell leukemia patients,intravenous cladribine treatment,intravenous cladribine
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要